| 21. | Spokesmen for Interneuron Pharmaceuticals point to other statistics on the amount of weight loss.
|
| 22. | Interneuron fell as much as 1 3 / 8 to 24 1 / 4.
|
| 23. | Interneuron Pharmaceutical Inc . fell 1 1 / 8 to 24 1 / 2.
|
| 24. | Interneuron Pharmaceuticals Inc . climbed 2 1 / 8 to 22 1 / 4.
|
| 25. | Interneuron Pharmaceuticals Inc . won FDA approval of its obesity treatment Redux last April.
|
| 26. | Interneuron shares declined 1 11 / 16 to close at 16 7 / 8.
|
| 27. | Interneuron is expected to challenge the data implicating Redux in heart-valve damage.
|
| 28. | Interneuron shares rose 1 / 16 to close at 9 7 / 8 today.
|
| 29. | Interneuron is hoping to shake the cloud cast over it by the failed Redux.
|
| 30. | Interneuron's stock fell 7 1 / 8 to 7 15 / 16.
|
